Trial intelligence / Profile preview

Anakinra for fever and mucositis in multiple myeloma

NCT03233776Phase 2Completed

Sponsor
Radboud University Medical Center
Start
Aug 2017
Primary completion
Apr 2020
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of anakinra in mucositis, febrile neutropenia (FN), sponsored by Radboud University Medical Center. Started Aug 2017; status: completed.

02

Drugs

anakinra
03

Conditions

mucositisfebrile neutropenia (FN)

Beyond the preview

Go deeper on NCT03233776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03233776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call